Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

0.2407

+0.0007 (0.29%)

At close: May 14, 2025, 4:00 PM

0.2340

-0.0067 (-2.78%)

After-hours: May 14, 2025, 7:51 PM EDT

Cellectar Biosciences Market Cap

Cellectar Biosciences has a market cap or net worth of $11.09 million as of May 14, 2025. Its market cap has decreased by -88.65% in one year.

Market Cap

11.09M

Enterprise Value

-2.37M

1-Year Change

-88.65%

Ranking

#5061

Market Cap Chart

Since November 10, 2005, Cellectar Biosciences's market cap has increased from $7.50M to $11.09M, an increase of 47.89%. That is a compound annual growth rate of 2.02%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	11.10M	-9.76%
Dec 31, 2024	12.30M	-63.82%
Dec 29, 2023	34.00M	112.50%
Dec 30, 2022	16.00M	-60.59%
Dec 31, 2021	40.60M	-27.24%
Dec 31, 2020	55.80M	164.45%
Dec 31, 2019	21.10M	185.14%
Dec 31, 2018	7.40M	-65.90%
Dec 29, 2017	21.70M	233.85%
Dec 30, 2016	6.50M	3.17%
Dec 31, 2015	6.30M	-73.08%
Dec 31, 2014	23.40M	10.38%
Dec 31, 2013	21.20M	-38.19%
Dec 31, 2012	34.30M	190.68%
Dec 30, 2011	11.80M	247.06%
Dec 31, 2010	3.40M	-97.92%
Dec 31, 2009	163.20M	1,484.47%
Dec 31, 2008	10.30M	-56.90%
Dec 31, 2007	23.90M	-22.90%
Dec 29, 2006	31.00M	-30.49%
Dec 30, 2005	44.60M	494.67%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	643.60B
Johnson & Johnson	352.56B
AbbVie	317.26B
Novo Nordisk	288.64B
UnitedHealth Group	281.65B
Abbott Laboratories	223.62B
Novartis AG	209.81B
AstraZeneca	209.59B

Market Cap Rankings